FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+6.11%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$40.7M
AUM Growth
+$40.7M
(-30%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-37.82%
Top 10 Holdings %
Top 10 Hldgs %
57.36%
Holding
159
New
20
Increased
12
Reduced
19
Closed
42
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$3.53M |
| 2 |
Amgen
AMGN
|
$2.08M |
| 3 |
iShares Biotechnology ETF
IBB
|
$1.87M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$1.79M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$1.51M |
Top Sells
| 1 |
Abbott
ABT
|
$5.39M |
| 2 |
Foot Locker
FL
|
$2.12M |
| 3 |
General Mills
GIS
|
$1.97M |
| 4 |
lululemon athletica
LULU
|
$1.38M |
| 5 |
United Therapeutics
UTHR
|
$1.32M |
Sector Composition
| 1 | Healthcare | 53.53% |
| 2 | Consumer Staples | 24.42% |
| 3 | Consumer Discretionary | 3.84% |
| 4 | Communication Services | 1.93% |
| 5 | Materials | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
TG Therapeutics
TGTX
$4.72B
| – | – |
0
| – | – |
|
152
T-Mobile US
TMUS
$288B
| – | – |
-1,300
| Closed | -$84K |
|
153
Tyson Foods
TSN
$20.1B
| – | – |
-14,788
| Closed | -$913K |
|
154
Unilever
UL
$156B
| – | – |
0
| – | – |
|
155
Ulta Beauty
ULTA
$23.9B
| – | – |
-1,000
| Closed | -$285K |
|
|
156
United Therapeutics
UTHR
$18.3B
| – | – |
-9,723
| Closed | -$1.32M |
|
157
Veeva Systems
VEEV
$44.1B
| – | – |
0
| – | – |
|
158
Vertex Pharmaceuticals
VRTX
$103B
| – | – |
-4,582
| Closed | -$501K |
|
159
Verizon
VZ
$185B
| – | – |
0
| – | – |
|